JESSICA VANCIL: Open Payments
NPI 1427367259 · ALTA LOMA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 33 payments from 17 companies in 2025. Trend: 2023 $295 · 2024 $609 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $92 |
| ABBVIE INC. | 3 | $69 |
| Lilly USA, LLC | 4 | $67 |
| Novo Nordisk Inc | 2 | $56 |
| Amgen Inc. | 3 | $48 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Madrigal Pharmaceuticals | 1 | $36 |
| Axsome Therapeutics, Inc. | 1 | $34 |
Products named: AIRSUPRA, The Cologuard Plus Collection Kit, UBRELVY, MOUNJARO, GEMTESA, NEXLETOL, REZDIFFRA, OTEZLA.
Industry payments across CA — which companies pay providers there.
